Cell segmentation methods for label-free contrast microscopy: review and comprehensive comparison T Vicar, J Balvan, J Jaros, F Jug, R Kolar, M Masarik, J Gumulec BMC bioinformatics 20, 1-25, 2019 | 166 | 2019 |
Multimodal holographic microscopy: distinction between apoptosis and oncosis J Balvan, A Krizova, J Gumulec, M Raudenska, Z Sladek, M Sedlackova, ... PloS one 10 (3), e0121674, 2015 | 91 | 2015 |
Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation M Raudenska, M Kratochvilova, T Vicar, J Gumulec, J Balvan, H Polanska, ... Scientific reports 9 (1), 1660, 2019 | 88 | 2019 |
Unexpected therapeutic effects of cisplatin M Raudenska, J Balvan, M Fojtu, J Gumulec, M Masarik Metallomics 11 (7), 1182-1199, 2019 | 84 | 2019 |
Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle J Gumulec, J Balvan, M Sztalmachova, M Raudenska, V Dvorakova, ... International Journal of Oncology 44 (3), 923-933, 2014 | 84 | 2014 |
The quantitative-phase dynamics of apoptosis and lytic cell death T Vicar, M Raudenska, J Gumulec, J Balvan Scientific reports 10 (1), 1566, 2020 | 61 | 2020 |
Cell death in head and neck cancer pathogenesis and treatment M Raudenská, J Balvan, M Masařík Cell Death & Disease 12 (2), 192, 2021 | 52 | 2021 |
Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a challenge for autophagy-based treatment of solid cancers M Raudenska, J Balvan, M Masarik Molecular Cancer 20, 1-27, 2021 | 44 | 2021 |
Mechanical Properties of cellulose fibers measured by Brillouin spectroscopy K Elsayad, G Urstöger, C Czibula, C Teichert, J Gumulec, J Balvan, ... Cellulose 27, 4209-4220, 2020 | 37 | 2020 |
Prostate-Specific Membrane Antigen-Targeted Site-Directed Antibody-Conjugated Apoferritin Nanovehicle Favorably Influences In Vivo Side Effects of Doxorubicin S Dostalova, H Polanska, M Svobodova, J Balvan, O Krystofova, ... Scientific reports 8 (1), 8867, 2018 | 36 | 2018 |
Oxidative stress resistance in metastatic prostate cancer: Renewal by self-eating J Balvan, J Gumulec, M Raudenska, A Krizova, P Stepka, P Babula, ... PLoS One 10 (12), e0145016, 2015 | 31 | 2015 |
Black phosphorus cytotoxicity assessments pitfalls: advantages and disadvantages of metabolic and morphological assays M Fojtů, J Balvan, M Raudenská, T Vičar, D Bouša, Z Sofer, M Masařík, ... Chemistry–A European Journal 25 (1), 349-360, 2019 | 24 | 2019 |
Prognostic significance of the tumour-adjacent tissue in head and neck cancers M Raudenska, M Sztalmachova, J Gumulec, M Fojtu, H Polanska, ... Tumor Biology 36, 9929-9939, 2015 | 24 | 2015 |
Oxidized polysaccharides for anticancer-drug delivery: What is the role of structure? L Münster, M Fojtů, Z Capáková, M Muchová, L Musilová, T Vaculovič, ... Carbohydrate Polymers 257, 117562, 2021 | 23 | 2021 |
Co-delivery of VP-16 and Bcl-2-targeted antisense on PEG-grafted oMWCNTs for synergistic in vitro anti-cancer effects in non-small and small cell lung cancer Z Heger, H Polanska, S Krizkova, J Balvan, M Raudenska, S Dostalova, ... Colloids and Surfaces B: Biointerfaces 150, 131-140, 2017 | 23 | 2017 |
Effect of zinc (II) ions on the expression of pro-and anti-apoptotic factors in high-grade prostate carcinoma cells M Sztalmachova, M Hlavna, J Gumulec, M Holubova, P Babula, J Balvan, ... Oncology reports 28 (3), 806-814, 2012 | 21 | 2012 |
Molecular response of 4T1-induced mouse mammary tumours and healthy tissues to zinc treatment M Sztalmachova, J Gumulec, M Raudenska, H Polanska, M Holubova, ... International journal of oncology 46 (4), 1810-1818, 2015 | 20 | 2015 |
Self‐Propelled Magnetic Dendrite‐Shaped Microrobots for Photodynamic Prostate Cancer Therapy X Peng, M Urso, J Balvan, M Masarik, M Pumera Angewandte Chemie International Edition 61 (48), e202213505, 2022 | 19 | 2022 |
Caveolin‐1 in oncogenic metabolic symbiosis M Raudenska, J Gumulec, J Balvan, M Masarik International journal of cancer 147 (7), 1793-1807, 2020 | 19 | 2020 |
17β-estradiol-containing liposomes as a novel delivery system for the antisense therapy of ER-positive breast cancer: An in vitro study on the MCF-7 cell line Z Heger, J Gumulec, N Cernei, K Tmejova, P Kopel, J Balvan, M Masarik, ... Oncology Reports 33 (2), 921-929, 2015 | 17 | 2015 |